RISPERIDONE ZENTIVA 1 mg, film-coated tablet scored 60 tablets, CIP 3400930229750
Active ingredients: Risperidone
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored60 tablets, CIP 3400930229750orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RISPERIDONE ZENTIVA 1 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 60 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Apr 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67402554CIP73022975CIP133400930229750Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RISPÉRIDONEcomprimé | 1,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.